|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 8, 404-409, Copyright © 1994 by European Association for Cardio-thoracic Surgery
P Kallis, JA Tooze, S Talbot, D Cowans, DH Bevan and T Treasure
Aspirin has an established benefit in reducing the incidence of coronary
events and vein graft occlusion. We have now assessed the risk of
pre-operative aspirin in a prospective, randomised, double-blind clinical
trial in 100 patients scheduled for elective coronary artery surgery. Any
prescribed aspirin and non-steroidal anti-inflammatory drugs were
discontinued 2 weeks pre-operatively and these were replaced by a randomly
assigned tablet of either aspirin 300 mg daily or placebo taken until the
day of surgery. Patient compliance was confirmed by serum and urinary
salicylate analysis. The two groups were similar in demographic
characteristics, bypass time, number of grafts placed and number of
internal mammary arteries used. All patients survived to be discharged home
(see Table). Aspirin decreases platelet aggregation to arachidonic acid and
to collagen both pre- and post-operatively. The benefit of pre-operative
aspirin has to be balanced against the risk of increasing post-operative
blood loss, re-exploration for excessive bleeding and transfusion
requirements.
ARTICLES
Pre-operative aspirin decreases platelet aggregation and increases post- operative blood loss--a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina
Harefield Hospital, Middlesex, UK.
This article has been cited by other articles:
![]() |
J. C.J. Sun, R. Whitlock, J. Cheng, J. W. Eikelboom, L. Thabane, M. A. Crowther, and K. H.T. Teoh The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies Eur. Heart J., April 2, 2008; 29(8): 1057 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vincentelli, B. Jude, and S. Belisle Antithrombotic therapy in cardiac surgery: [Traitement antithrombotique en chirurgie cardiaque]. Can J Anesth, June 1, 2006; 53(6_suppl): S89 - S102. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Morawski, M. Sanak, M. Cisowski, M. Szczeklik, W. Szczeklik, J. Dropinski, T. Waclawczyk, R. Ulczok, and A. Bochenek Prediction of the excessive perioperative bleeding in patients undergoing coronary artery bypass grafting: Role of aspirin and platelet glycoprotein IIIa polymorphism J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 791 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Bybee, B. D. Powell, U. Valeti, A. G. Rosales, S. L. Kopecky, C. Mullany, and R. S. Wright Preoperative Aspirin Therapy Is Associated With Improved Postoperative Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Circulation, August 30, 2005; 112(9_suppl): I-286 - I-292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C.J. Sun, M. A. Crowther, T. E. Warkentin, A. Lamy, and K. H.T. Teoh Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery? Circulation, August 16, 2005; 112(7): e85 - e90. [Full Text] [PDF] |
||||
![]() |
C. P. Cannon, S. R. Mehta, and S. F. Aranki Balancing the Benefit and Risk of Oral Antiplatelet Agents in Coronary Artery Bypass Surgery Ann. Thorac. Surg., August 1, 2005; 80(2): 768 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Ferraris, S. P. Ferraris, D. J. Moliterno, P. Camp, J. M. Walenga, H. L. Messmore, W. P. Jeske, F. H. Edwards, D. Royston, D. M. Shahian, et al. The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary) Ann. Thorac. Surg., April 1, 2005; 79(4): 1454 - 1461. [Full Text] [PDF] |
||||
![]() |
C. M. Samama and C. Baillard L'anesthesie loco-regionale neuraxiale ne devrait plus etre utilisee en chirurgie vasculaire Can J Anesth, January 1, 2001; 48(1): 72 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Stein, J. E. Dalen, S. Goldman, and P. Theroux Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts Chest, January 1, 2001; 119(1_suppl): 278S - 282S. [Full Text] [PDF] |
||||
![]() |
L. J. Dacey, J. J. Munoz, E. R. Johnson, B. J. Leavitt, C. T. Maloney, J. R. Morton, E. M. Olmstead, J. D. Birkmeyer, and G. T. O'Connor Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients Ann. Thorac. Surg., December 1, 2000; 70(6): 1986 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hop, G. J. E. Rinkel, A. Algra, J. W. B. van der Sprenkel, and J. van Gijn Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage Neurology, February 22, 2000; 54(4): 872 - 878. [Abstract] [Full Text] [PDF] |
||||
![]() |
Drugs in the peri-operative period: 4 - Cardiovascular drugs DTB, December 1, 1999; 37(12): 89 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery) J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347. [Full Text] [PDF] |
||||
![]() |
M S Avidan, B J Hunt, J. Soar, S. J Howell, J. Sonksen, R. Gray, and P. Hutton Safer non-cardiac surgery for patients with coronary artery disease BMJ, July 31, 1999; 319(7205): 320 - 320. [Full Text] |
||||
![]() |
T. Treasure and K. D MacRae Minimisation: the platinum standard for trials? BMJ, August 8, 1998; 317(7155): 362 - 363. [Full Text] |
||||
![]() |
M. J. Unsworth-White, A. Herriot, O. Valencia, J. Poloniecki, E. E. John Smith, A. J. Murday, D. J. Parker, and T. Treasure Resternotomy for Bleeding After Cardiac Operation: A Marker for Increased Morbidity and Mortality Ann. Thorac. Surg., March 1, 1995; 59(3): 664 - 667. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |